NOBIVAC® 3-RABIES

NOBIVAC® 3-RABIES

CatsDogs

Diseases

Canine and Feline Class

>Vaccines – 3-year immunity

NOBIVAC® 3-RABIES



Biological name
Rabies Vaccine, KILLED VIRUS


Provides maximum protection against rabies in dogs and cats for at least 3 years.

Features and benefits

Produced on an established cell line that has been extensively tested1

  • A duration of immunity study demonstrated that a 1-mL dose met federal guidelines for protection of dogs and cats against virulent challenge administered 3 years after vaccination1

Indication

  • Approved for the vaccination of healthy dogs and cats as an aid in preventing rabies
  • Recommended for use in healthy dogs and cats 3 months of age or older
  • Approved for the vaccination of healthy sheep and cattle as an aid in preventing rabies
  • Approved for use in healthy sheep and cattle 3 months of age or older

Safety information

  • Proven to be uniformly safe in experimental tests, with no significant adverse reactions in extensive clinical trials1

Please see the product label for further safety information.

Dosage and administration

For healthy dogs and cats 3 months or older:

  • Subcutaneous 1-mL injection for cats
  • Subcutaneous or intramuscular 1-mL injection for dogs
  • A repeat dose should be administered 1 year later
  • Subsequent revaccination every 3 years with 1 dose is recommended
  • Available in a 50 x 1-mL dose and 5 x 10-mL dose vials

For healthy cattle and sheep 3 months or older:

  • Intramuscular 2-mL injection for sheep or cattle
  • A repeat dose should be administered 1 year later

For further information, including complete directions and warnings, please see the product label.

Product label(s) and MSDS

Reference:

  1. Data on file, Merck Animal Health.